Market Whales and Their Recent Bets on AMGN Options
Market Whales and Their Recent Bets on AMGN Options
Whales with a lot of money to spend have taken a noticeably bearish stance on Amgen.
有很多錢可以花的鯨魚對安進採取了明顯的看跌立場。
Looking at options history for Amgen (NASDAQ:AMGN) we detected 17 trades.
查看安進（納斯達克股票代碼：AMGN）的期權歷史記錄，我們發現了17筆交易。
If we consider the specifics of each trade, it is accurate to state that 23% of the investors opened trades with bullish expectations and 58% with bearish.
如果我們考慮每筆交易的具體情況，可以準確地說，有23％的投資者以看漲的預期開盤，58％的投資者持看跌預期。
From the overall spotted trades, 9 are puts, for a total amount of $557,464 and 8, calls, for a total amount of $303,400.
在已發現的全部交易中，有9筆是看跌期權，總額爲557,464美元，8筆看漲期權，總額爲303,400美元。
Expected Price Movements
預期的價格走勢
Taking into account the Volume and Open Interest on these contracts, it appears that whales have been targeting a price range from $240.0 to $310.0 for Amgen over the last 3 months.
考慮到這些合約的交易量和未平倉合約，在過去的3個月中，鯨魚似乎一直將安進的價格定在240.0美元至310.0美元之間。
Volume & Open Interest Trends
交易量和未平倉合約趨勢
Looking at the volume and open interest is an insightful way to conduct due diligence on a stock.
查看交易量和未平倉合約是一種對股票進行盡職調查的有見地的方法。
This data can help you track the liquidity and interest for Amgen's options for a given strike price.
這些數據可以幫助您跟蹤給定行使價下安進期權的流動性和利息。
Below, we can observe the evolution of the volume and open interest of calls and puts, respectively, for all of Amgen's whale activity within a strike price range from $240.0 to $310.0 in the last 30 days.
下面，我們可以分別觀察安進所有鯨魚活動的看漲期權和未平倉合約在過去30天內在240.0美元至310.0美元之間的行使價區間內的變化。
Amgen Option Activity Analysis: Last 30 Days
安進期權活動分析：過去 30 天
Largest Options Trades Observed:
觀察到的最大期權交易：
| Symbol | PUT/CALL | Trade Type | Sentiment | Exp. Date | Ask | Bid | Price | Strike Price | Total Trade Price | Open Interest | Volume |
|---|---|---|---|---|---|---|---|---|---|---|---|
| AMGN | PUT | SWEEP | BEARISH | 09/20/24 | $15.55 | $14.8 | $15.6 | $300.00 | $173.1K | 247 | 40 |
| AMGN | PUT | TRADE | BEARISH | 06/21/24 | $6.25 | $6.05 | $6.2 | $300.00 | $62.0K | 2.0K | 10 |
| AMGN | PUT | TRADE | BEARISH | 05/17/24 | $2.53 | $2.31 | $2.45 | $300.00 | $61.2K | 818 | 767 |
| AMGN | PUT | SWEEP | BULLISH | 05/24/24 | $6.45 | $5.5 | $5.58 | $302.50 | $55.9K | 0 | 204 |
| AMGN | CALL | TRADE | BEARISH | 06/20/25 | $35.7 | $34.2 | $34.25 | $310.00 | $51.3K | 97 | 0 |
| 符號 | 看跌/看漲 | 交易類型 | 情緒 | Exp。日期 | 問 | 出價 | 價格 | 行使價 | 總交易價格 | 未平倉合約 | 音量 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| AMGN | 放 | 掃 | 粗魯的 | 09/20/24 | 15.55 美元 | 14.8 美元 | 15.6 美元 | 300.00 美元 | 173.1 萬美元 | 247 | 40 |
| AMGN | 放 | 貿易 | 粗魯的 | 06/21/24 | 6.25 美元 | 6.05 美元 | 6.2 美元 | 300.00 美元 | 62.0 萬美元 | 2.0K | 10 |
| AMGN | 放 | 貿易 | 粗魯的 | 05/17/24 | 2.53 美元 | 2.31 美元 | 2.45 美元 | 300.00 美元 | 61.2 萬美元 | 818 | 767 |
| AMGN | 放 | 掃 | 看漲 | 05/24/24 | 6.45 美元 | 5.5 美元 | 5.58 美元 | 302.50 美元 | 55.9 萬美元 | 0 | 204 |
| AMGN | 打電話 | 貿易 | 粗魯的 | 06/20/25 | 35.7 美元 | 34.2 美元 | 34.25 美元 | 310.00 美元 | 51.3 萬美元 | 97 | 0 |
About Amgen
關於安進
Amgen is a leader in biotechnology-based human therapeutics. Flagship drugs include red blood cell boosters Epogen and Aranesp, immune system boosters Neupogen and Neulasta, and Enbrel and Otezla for inflammatory diseases. Amgen introduced its first cancer therapeutic, Vectibix, in 2006 and markets bone-strengthening drug Prolia/Xgeva (approved 2010) and Evenity (2019). The acquisition of Onyx bolstered the firm's therapeutic oncology portfolio with Kyprolis. Recent launches include Repatha (cholesterol-lowering), Aimovig (migraine), Lumakras (lung cancer), and Tezspire (asthma). The 2023 Horizon acquisition brings several rare-disease drugs, including thyroid eye disease drug Tepezza. Amgen also has a growing biosimilar portfolio.
安進是基於生物技術的人體療法的領導者。旗艦藥物包括紅細胞增強劑Epogen和Aranesp、免疫系統增強劑Neupogen和Neulasta以及治療炎症性疾病的Enbrel和Otezla。安進於2006年推出了其首款癌症療法Vectibix，並銷售強化骨骼的藥物Prolia/Xgeva（2010年獲得批准）和Evenity（2019年）。對Onyx的收購加強了該公司與Kyprolis合作的治療腫瘤學產品組合。最近推出的產品包括Repatha（降膽固醇）、Aimovig（偏頭痛）、Lumakras（肺癌）和Tezspire（哮喘）。2023年Horizon的收購帶來了幾種罕見疾病藥物，包括甲狀腺眼病藥物Tepezza。安進的生物仿製藥產品組合也在不斷增長。
Following our analysis of the options activities associated with Amgen, we pivot to a closer look at the company's own performance.
在分析了與安進相關的期權活動之後，我們將轉向仔細研究公司自身的表現。
Current Position of Amgen
安進的現狀
- Currently trading with a volume of 852,384, the AMGN's price is up by 0.92%, now at $303.07.
- RSI readings suggest the stock is currently may be overbought.
- Anticipated earnings release is in 85 days.
- AMGN目前的交易量爲852,384美元，價格上漲了0.92％，目前爲303.07美元。
- RSI讀數表明該股目前可能處於超買狀態。
- 預計業績將在85天后發佈。
Trading options involves greater risks but also offers the potential for higher profits. Savvy traders mitigate these risks through ongoing education, strategic trade adjustments, utilizing various indicators, and staying attuned to market dynamics. Keep up with the latest options trades for Amgen with Benzinga Pro for real-time alerts.
交易期權涉及更大的風險，但也提供了更高利潤的潛力。精明的交易者通過持續的教育、戰略貿易調整、利用各種指標以及隨時關注市場動態來降低這些風險。使用Benzinga Pro了解安進的最新期權交易，以獲得實時警報。
譯文內容由第三人軟體翻譯。